Literature DB >> 10759467

Rapid screening of high-risk patients for disorders of purine and pyrimidine metabolism using HPLC-electrospray tandem mass spectrometry of liquid urine or urine-soaked filter paper strips.

T Ito1, A B van Kuilenburg, A H Bootsma, A J Haasnoot, A van Cruchten, Y Wada, A H van Gennip.   

Abstract

BACKGROUND: A rapid and specific screening method for patients at risk of inherited disorders of purine and pyrimidine metabolism is desirable because symptoms are varied and nonspecific. The aim of this study was to develop a rapid and specific method for screening with use of liquid urine samples or urine-soaked filter paper strips.
METHODS: Reverse-phase HPLC was combined with electrospray ionization (ESI), tandem mass spectrometry (MS/MS), and detection performed by multiple reaction monitoring. Transitions and instrument settings were established for 17 purines or pyrimidines. Stable-isotope-labeled reference compounds were used as internal standards when available.
RESULTS: Total analysis time of this method was 15 min, approximately one-third that of conventional HPLC with ultraviolet detection. Recoveries were 96-107% in urine with added analyte, with two exceptions (hypoxanthine, 64%; xanthine, 79%), and 89-110% in urine-soaked filter paper strips, with three exceptions (hypoxanthine, 65%; xanthine, 77%; 5-hydroxymethyluracil, 80%). The expected abnormalities were easily found in samples from patients with purine nucleoside phosphorylase deficiency, ornithine transcarbamylase deficiency, molybdenum cofactor deficiency, adenylosuccinase deficiency, or dihydropyrimidine dehydrogenase deficiency.
CONCLUSIONS: HPLC-ESI MS/MS of urine allows rapid screening for disorders of purine and pyrimidine metabolism. The filter paper strips offer the advantage of easy collection, transport, and storage of the urine samples.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10759467

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

Review 1.  Advances in analytical mass spectrometry to improve screening for inherited metabolic diseases.

Authors:  Wulf Röschinger; Bernhard Olgemöller; Ralph Fingerhut; Bernhard Liebl; Adelbert A Roscher
Journal:  Eur J Pediatr       Date:  2003-11-14       Impact factor: 3.183

2.  Comprehensive analysis of pyrimidine metabolism in 450 children with unspecific neurological symptoms using high-pressure liquid chromatography-electrospray ionization tandem mass spectrometry.

Authors:  C Schmidt; U Hofmann; D Kohlmüller; T Mürdter; U M Zanger; M Schwab; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry.

Authors:  James J Pitt
Journal:  Clin Biochem Rev       Date:  2009-02

4.  Electrospray ionisation mass spectrometry: principles and clinical applications.

Authors:  C S Ho; C W K Lam; M H M Chan; R C K Cheung; L K Law; L C W Lit; K F Ng; M W M Suen; H L Tai
Journal:  Clin Biochem Rev       Date:  2003

5.  Metabolic disorders of purine metabolism affecting the nervous system.

Authors:  H A Jinnah; Richard L Sabina; Georges Van Den Berghe
Journal:  Handb Clin Neurol       Date:  2013

6.  Detection of neonatal argininosuccinate lyase deficiency by serum tandem mass spectrometry.

Authors:  S Stadler; K Gempel; I Bieger; B F Pontz; K D Gerbitz; M F Bauer; S Hofmann
Journal:  J Inherit Metab Dis       Date:  2001-06       Impact factor: 4.982

7.  Dihydropyrimidine dehydrogenase deficiency and acute neurological presentation.

Authors:  A Fiumara; A B P van Kuilenburg; U Caruso; C Nucifora; E Marzullo; R Barone; C Meli; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 8.  Inborn errors of purine and pyrimidine metabolism.

Authors:  A Jurecka
Journal:  J Inherit Metab Dis       Date:  2009-03-15       Impact factor: 4.982

9.  Phenotypic correction of ornithine transcarbamylase deficiency using low dose helper-dependent adenoviral vectors.

Authors:  Nicola Brunetti-Pierri; Christian Clarke; Viraj Mane; Donna J Palmer; Brendan Lanpher; Qin Sun; William O'Brien; Brendan Lee
Journal:  J Gene Med       Date:  2008-08       Impact factor: 4.565

10.  Opiate DAU screening using dried urine specimens.

Authors:  Danni L Meany; William Clarke
Journal:  Clin Chim Acta       Date:  2008-12-03       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.